S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

RIGL Rigel Pharmaceuticals Inc

1.05

-0.02 (-1.87%)

After Hours

Last Updated: 06:40:50

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From Mar 2024 to May 2024

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals Inc News

Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update
Tuesday 30 April 2024 (9 hours ago) • PR Newswire (US)

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Thursday 11 April 2024 (3 weeks ago) • PR Newswire (US)

Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma
Thursday 4 April 2024 (4 weeks ago) • PR Newswire (US)

Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
Tuesday 12 March 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Wednesday 6 March 2024 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update
Wednesday 28 February 2024 (2 months ago) • PR Newswire (US)

More Rigel Pharmaceuticals Inc News Articles

Australia And New Zealan...

Sterling vs AUD

Westpac Banking

Verizon Communications

Invesco QQQ Trust Series 1

Australian SE All Ordina...

Commonwealth Bank Of Aus...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions